Your account is not claimed yet. You can sign up with ORCID to claim your account.

Won-Sik Shin

Years Active: 2018-2023
Publications (10 Years): 6

ICM Co., Ltd.

Yonsei University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

ICM Co., Ltd. Dec 1o 2019

South Korea

Team Leader :: Process Development Team

Education History

Yonsei University Sep 1o 2005 - Aug 25o 2013

South Korea

PHD :: Biochemistry

Publications

Won-Sik Shin, Si Won Oh, Han Na Park, Jae Hoon Kim, Seung-Taek Lee
Knockdown of PTK7 Reduces the Oncogenic Potential of Breast Cancer Cells by Impeding Receptor Tyrosine Kinase Signaling. International journal of molecular sciences 24 (15) (2023)
Jae Hoon Kim, Won-Sik Shin, Se-Ra Lee, Sanggil Kim, So-Young Choi, Seung-Taek Lee
Anti-PTK7 Monoclonal Antibodies Exhibit Anti-Tumor Activity at the Cellular Level and in Mouse Xenograft Models of Esophageal Squamous Cell Carcinoma. International journal of molecular sciences 23 (20) (2022)
Won-Sik Shin, Mi-Kyung Park, Jae Hoon Kim, Si Won Oh, Ji-Yun Jang, Ho Lee, Seung-Taek Lee
PTK7, a Catalytically Inactive Receptor Tyrosine Kinase, Increases Oncogenic Phenotypes in Xenograft Tumors of Esophageal Squamous Cell Carcinoma KYSE-30 Cells. International journal of molecular sciences 23 (4) (2022)
Si Won Oh, Won-Sik Shin, Seung-Taek Lee
Anti-PTK7 Monoclonal Antibodies Inhibit Angiogenesis by Suppressing PTK7 Function. Cancers 14 (18) (2022)
Won-Sik Shin, Mi Kyung Park, Young Hun Lee, Kyung Woo Kim, Ho Lee, Seung-Taek Lee
The catalytically defective receptor protein tyrosine kinase EphA10 promotes tumorigenesis in pancreatic cancer cells. Cancer science 111 (9) (2020)
Won-Sik Shin, Jungsoo Gim, Sungho Won, Seung-Taek Lee
Biphasic regulation of tumorigenesis by PTK7 expression level in esophageal squamous cell carcinoma. Scientific reports 8 (1) (2018)

Won-Sik Shin.css-eqlu8i{font-size:small;padding-left:4px;}